NCT00006213
- Conditions
- Adult Acute Promyelocytic Leukemia (M3), Anemia, Anemia, Refractory, +37 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Myeloproliferative Disorders
Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.
1,108 public trials
144 recruiting studies
Myeloproliferative Disorders trial results
NCT00006053
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States
NCT00008359
- Conditions
- Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00030394
- Conditions
- Bone Marrow Diseases, Childhood Chronic Myelogenous Leukemia, Chronic Disease, +14 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
NCT00053963
- Conditions
- Astrocytoma, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +75 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
NCT00093418
- Conditions
- Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +29 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
NCT00098826
- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +60 more
- Locations
-
- Case Western Reserve University Cleveland, Ohio, United States
NCT00947830
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- Juravinski Cancer Centre Hamilton, Ontario, Canada
NCT00131989
- Conditions
- Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +37 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Completed
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00112853
- Conditions
- Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +27 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States